Document Detail

Propranolol treatment in life-threatening airway hemangiomas: A case series and review of literature.
MedLine Citation:
PMID:  24074695     Owner:  NLM     Status:  Publisher    
OBJECTIVES: Infantile hemangiomas (IHs) in the airway may be potentially life-threatening during the proliferative phase. Available treatments like oral corticosteroids (OCS) and chemotherapeutic agents usually showed variable responses and serious side effects. Propranolol is a new and promising treatment option.
METHODS: A case series of five IH patients with airway involvement is presented, supplemented with a review of literature. Propranolol treatment (2.0-3.0mg/kg/day) was initiated between 3 weeks and 6 months of age. Three cases were treated with propranolol monotherapy, 2 cases with OCS primarily and propranolol secondarily, in which treatment with OCS could be reduced rapidly.
RESULTS: In our case series a dramatic, fast response was observed in all cases, with a permanent effect after discontinuation in four cases. In one patient a relapse of airway problems occurred two months after discontinuation of propranolol at 16 months of age; this resolved after re-start of propranolol. Review of literature together with these five cases showed 81 patients with airway IHs treated with propranolol. Propranolol was effective in 90% of the cases and seven patients were classified as non-responders. Eight IHs relapsed while weaning of propranolol or after discontinuation; dose adjustment or restart was effective in most cases but one patient appeared resistant to therapy.
CONCLUSIONS: Propranolol seems to be a rapidly effective and safe treatment strategy for most IHs obstructing the airway. Because of the fast and important effects of propranolol, randomized controlled trials are hardly justifiable for this specific, relatively rare but, acute treatment indication. Despite the efficacy of propranolol, close monitoring of the patients with an airway IH is required, considering the risk of relapse of symptoms during or after treatment and the reported resistance to propranolol in at least 9% of the published cases. The dose and duration of treatment should be high and long enough to prevent relapse. Further research should focus on the optimal treatment protocol; the actual percentage of non-responders and also the mechanism of resistance to propranolol is unknown and needs to be illuminated.
Ilse Jantine Broeks; Denise Josephina Johanna Hermans; Anne Catherina Maria Dassel; Catharina Joanna Maria van der Vleuten; Ingrid Mathilde van Beynum
Related Documents :
1659935 - Overview of viridans streptococcal endocarditis: clinical analysis of 99 cases.
8701385 - Fragmentation hemolysis: an unusual indication for valve replacement in native valve in...
24413495 - Provider characteristics associated with guideline-nonadherent gonorrhea treatment, mas...
3878295 - Diphtheritic septicaemia and probable endocarditis: a case report and review of the lit...
19292335 - Chondromyxoid fibroma of the lumbar spine in a pediatric patient.
18971055 - Deformities associated with the suture-bridge technique for full-thickness rotator cuff...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-8-22
Journal Detail:
Title:  International journal of pediatric otorhinolaryngology     Volume:  -     ISSN:  1872-8464     ISO Abbreviation:  Int. J. Pediatr. Otorhinolaryngol.     Publication Date:  2013 Aug 
Date Detail:
Created Date:  2013-9-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8003603     Medline TA:  Int J Pediatr Otorhinolaryngol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.
Department of Pediatrics, Deventer Hospital, Deventer, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Psychosocial correlates of sleep quality and architecture in women with metastatic breast cancer.
Next Document:  Paediatric adenotonsillectomy as a daycase for obstructive sleep apnoea: How we do it in a tertiary ...